Acid-degradable polyurethane particles for protein-based vaccines:: Biological evaluation and in vitro analysis of particle degradation products

被引:39
作者
Bachelder, Eric M.
Beaudette, Tristan T.
Broaders, Kyle E.
Paramonov, Sergey E.
Dashe, Jesse
Frechet, Jean M. J. [1 ]
机构
[1] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA
基金
美国国家卫生研究院;
关键词
vaccination; microparticles; acid-degradable materials; polyacetal; CTL; LC-MS;
D O I
10.1021/mp800068x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Acid-degradable particles containing a model protein antigen, ovalbumin, were prepared from a polyurethane with acetal moieties embedded throughout the polymer, and characterized by dynamic light scattering and transmission electron microscopy. The small molecule degradation byproduct of the particles was synthesized and tested in vitro for toxicity indicating an LC50 of 12,500 mu g/mL. A new liquid chromatography-mass spectrometry technique was developed to monitor the in vitro degradation of these particles. The degradation byproduct inside RAW macrophages was at its highest level after 24 h of culture and was efficiently exocytosed until it was no longer detectable after 4 days. When tested in vitro, these particles induced a substantial increase in the presentation of the immunodominant ovalbumin-derived peptide SIINFEKL in both macrophages and dendritic cells. In addition, vaccination with these particles generated a cytotoxic T-lymphocyte response that was superior to both free ovalbumin and particles made from an analogous but slower-degrading acid-labile polyurethane polymer. Overall, we present a fully degradable polymer system with nontoxic byproducts, which may find use in various biomedical applications including protein-based vaccines.
引用
收藏
页码:876 / 884
页数:9
相关论文
共 40 条
[1]   T-cell control of IL-12p75 production [J].
Abdi, K. ;
Singh, N. ;
Matzinger, P. .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2006, 64 (02) :83-92
[2]   Sonication parameters for the preparation of biodegradable nanocapsules of controlled size by the double emulsion method [J].
Bilati, U ;
Allémann, E ;
Doelker, E .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2003, 8 (01) :1-9
[3]   Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates [J].
Caliceti, P ;
Veronese, FM .
ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (10) :1261-1277
[4]   Stimulation of HIV gp120-specific cytolytic T lymphocyte responses in vitro and in vivo using a detoxified pertussis toxin vector [J].
Carbonetti, NH ;
Tuskan, RG ;
Lewis, GK .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (09) :819-827
[5]   Responses of peptide-specific T cells to stimulation with polystyrene beads carrying HLA class I molecules loaded with single peptides [J].
Chersi, A ;
Galati, R ;
Accapezzato, D ;
Francavilla, V ;
Barnaba, V ;
Butler, RH ;
Tanigaki, N .
JOURNAL OF IMMUNOLOGICAL METHODS, 2004, 291 (1-2) :79-91
[6]   Vaccination against polio should not be stopped [J].
Chumakov, Konstantin ;
Ehrenfeld, Ellie ;
Wimmer, Eckard ;
Agol, Vadim I. .
NATURE REVIEWS MICROBIOLOGY, 2007, 5 (12) :952-U13
[7]   Comparison of diafiltration and tangential flow filtration for purification of nanoparticle suspensions [J].
Dalwadi, G ;
Benson, HAE ;
Chen, Y .
PHARMACEUTICAL RESEARCH, 2005, 22 (12) :2152-2162
[8]   Quantitative monitoring of dermal and inhalation exposure to 1,6-hexamethylene diisocyanate monomer and oligomers [J].
Fent, Kenneth W. ;
Jayaraj, Karupiah ;
Ball, Louise M. ;
Nylander-French, Leena A. .
JOURNAL OF ENVIRONMENTAL MONITORING, 2008, 10 (04) :500-507
[9]   Size-dependent immunogenicity: Therapeutic and protective properties of nano-vaccines against tumors [J].
Fifis, T ;
Gamvrellis, A ;
Crimeen-Irwin, B ;
Pietersz, GA ;
Li, J ;
Mottram, PL ;
McKenzie, IFC ;
Plebanski, M .
JOURNAL OF IMMUNOLOGY, 2004, 173 (05) :3148-3154
[10]   Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model [J].
Foged, C ;
Brodin, B ;
Frokjaer, S ;
Sundblad, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 298 (02) :315-322